We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Chattem, Inc. (MM) | NASDAQ:CHTT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 93.49 | 0 | 00:00:00 |
From Mar 2020 to Mar 2025
French drug company Sanofi-Aventis (SNY) Tuesday said it has obtained antitrust clearance in connection with its $93.50 per share tender offer for Chattem, Inc (CHTT). MAIN FACTS:
MAIN FACTS:
- The waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976 has expired, which satisfies one of the conditions of the tender offer.
- The tender offer remains subject to the other conditions described in the Offer to Purchase filed January 11, 2010
- The tender offer is scheduled to expire at 1200 midnight, New York City time, on February 8, unless the tender offer is extended.
- By Paris Bureau, Dow Jones Newswires; +331-4017-1740; djnews.paris@dowjones.com
1 Year Chattem, Inc. (MM) Chart |
1 Month Chattem, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
